Year 2019, Volume 19, Issue 1, Pages 199 - 204 2019-03-22

How Should Counseling Be Done in Health Screenings?
Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır?

Basri Furkan Dağcıoğlu [1] , Yusuf Üstü [2]

27 51

Periodic Health Evaluation (PHE) is the assessment at a frequency that is shaped according to the age, gender, and risk factors of healthy looking people. An important component of this assessment is screening tests. The screening test to be performed should be acceptable to persons. It is important for physicians to inform patients about the benefit / damage ratio related to the suggested PHE by the principles of interviewer model.

Periyodik Sağlık Muayenesi (PSM), sağlıklı görünen kişilerin yaş, cinsiyet ve risk faktörlerine göre belirlenen sıklıkta değerlendirilmesidir. Bu değerlendirmenin önemli bir bileşeni de tarama testleridir. Uygulanacak tarama testi kişiler tarafindan kabul edilebilir olmalıdır. Hekimlerin önerilen PSM ile ilgili yarar/zarar oranı hususunda, görüşmeci model prensipleri doğrultusunda hastaları bilgilendirmesi önemlidir. 
  • Mazıcıoğlu M, Uzuner A. Aile Doktorları için Kurs Notları, 1.Aşama. Ankara: TC.Sağlık Bakanlığı; 2004:99-109.
  • Kligman EW, Hale FA. Family Medicine: Principles and Practice. Taylor RB, ed. Family Medicine, Principles and Practice. 5th ed. New York: Springer-Verlag; 1997:29-52.
  • United States Preventive Services Task Force (USPSTF): Guide to Clinical Preventive Services, U.S. Department of Health and Human Services Agency for Healthcare Research and Quality. 2019; https://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b-recommendations/. Erişim Tarihi: 03.03.2019.
  • Birtwhistle R, Bell N, Thombs B, Grad R, Dickinson J. Periodic preventive health visits: a more appropriate approach to delivering preventive services. Canadian Family Physician. 2017;63(11):824-6.
  • Canadian Task Force on Preventive Health Care. https://canadiantaskforce.ca/guidelines/published-guidelines/. Erişim Tarihi: 03.03.2019.
  • Summary of Recommendations for Clinical Preventive Services. 2017; https://www.aafp.org/dam/AAFP/documents/patient_care/clinical_recommendations/cps- recommendations.pdf. Erişim Tarihi: 05.03.2019.
  • Viera A, Power D. Koruma ve Taramaya Genel Bakış. Sloane PD, ed. (Palandüz A.çev.) Aile Hekimliğinin Esasları. 6. ed. İstanbul: Medikal Sağlık ve Yayıncılık; 2015:29- 35.
  • Warner EA, Herold AH. Interpreting Laboratory Tests. Rakel RE, ed. Textbook of Family Practice. Philadelphia: Elsevier Saunders; 2016:157-80.
  • Galen RS, Gambino SR. Beyond normality: The Predictive Value and Efficacy of Medical Diagnosis. New York: John Wiley & Sons; 1975:171-5.
  • Duane M, Mishori R. Sağlam Erişkin Bakımı. Sloane PD, ed. (Palandüz A.çev.) Aile Hekimliğinin Esasları. 6. ed. İstanbul: Medikal Sağlık ve Yayıncılık; 2015:61-75.
  • Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-37, W237-42.
  • Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. Annals of Internal Medicine. 2009;151(10):738-47.
  • Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, DL M. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481-92.
  • Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10-20.
  • van Ravesteyn NT, Miglioretti DL, Stout NK, et al. What level of risk tips the balance of benefits and harms to favor screening mammography starting at age 40? Ann Intern Med. 2012;156(9):609-17.
  • Grossman DC, Curry SJ, Owens DK, et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(18):1901-13.
  • Hamrick IM. Reports From the AAFP FMX Conference: Top 10 Updates in EBM. https://www.practiceupdate.com/content/reports-from-the-aafp-fmx-conference-top-10- updates-in-ebm/75261/62. Erişim Tarihi: 10.03.2019.
  • Campos-Outcalt D. Preventive Health Care. Rakel RE, ed. Textbook of Family Medicine. 9th ed.: Elsevier; 2016:85-7.
  • Lalkhen AG, McCluskey A. Clinical tests: sensitivity and specificity. Continuing Education in Anaesthesia Critical Care & Pain. 2008;8(6):221-3.
  • Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ. 1998;317:307-12.
  • Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012;156(7):491-9.
  • Kopans DB. The positive predictive value of mammography. AJR Am J Roentgenol. 1992;158(3):521-6.
  • Grimes DA, Schulz KF. Uses and abuses of screening tests. The Lancet. 2002;359(9309):881-4.
  • Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med. 2012;156(5):340-9.
  • Guideline on Impaired Vision. Canadian Task Force on Preventive Health Care;2018. https://canadiantaskforce.ca/guidelines/published-guidelines/impaired-vision/. Erişim Tarihi: 10.03.2019.
  • Altınel M, Akçakaya MA. Yaşlılık ve Göz. Okmeydanı Tıp Dergisi. 2013;29(2):110-5.
  • Ohuchi N, Suzuki A, Sobue T, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti- cancer Randomized Trial (J-START): a randomised controlled trial. The Lancet. 2016;387(10016):341-8.
  • Starting M. Mammography screening for breast cancer. N Engl J Med. 2012;367:31.
  • Aile Hekimliği Uygulamasında Önerilen Periyodik Muayeneleri ve Tarama Testleri Rehberi. Ankara: T.C. Sağlık Bakanlığı Aile Hekimliği Eğitim ve Geliştirme D. Başkanlığı;2015. https://www.pediatridunyasi.org/common/getCommonFile.aspx?document=200026. Erişim Tarihi: 10.03.2019.
Primary Language tr
Subjects Health Care Sciences and Services
Journal Section Reviews
Authors

Orcid: 0000-0003-1037-9942
Author: Basri Furkan Dağcıoğlu (Primary Author)
Institution: ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ

Orcid: 0000-0001-5727-8431
Author: Yusuf Üstü
Institution: ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ

Bibtex @review { amj542438, journal = {Ankara Medical Journal}, issn = {}, eissn = {2148-4570}, address = {Ankara Yildirim Beyazit University}, year = {2019}, volume = {19}, pages = {199 - 204}, doi = {10.17098/amj.542438}, title = {Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır?}, key = {cite}, author = {Dağcıoğlu, Basri Furkan and Üstü, Yusuf} }
APA Dağcıoğlu, B , Üstü, Y . (2019). Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır?. Ankara Medical Journal, 19 (1), 199-204. DOI: 10.17098/amj.542438
MLA Dağcıoğlu, B , Üstü, Y . "Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır?". Ankara Medical Journal 19 (2019): 199-204 <http://www.ankaramedicaljournal.com/issue/44012/542438>
Chicago Dağcıoğlu, B , Üstü, Y . "Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır?". Ankara Medical Journal 19 (2019): 199-204
RIS TY - JOUR T1 - Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır? AU - Basri Furkan Dağcıoğlu , Yusuf Üstü Y1 - 2019 PY - 2019 N1 - doi: 10.17098/amj.542438 DO - 10.17098/amj.542438 T2 - Ankara Medical Journal JF - Journal JO - JOR SP - 199 EP - 204 VL - 19 IS - 1 SN - -2148-4570 M3 - doi: 10.17098/amj.542438 UR - https://doi.org/10.17098/amj.542438 Y2 - 2019 ER -
EndNote %0 Ankara Medical Journal Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır? %A Basri Furkan Dağcıoğlu , Yusuf Üstü %T Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır? %D 2019 %J Ankara Medical Journal %P -2148-4570 %V 19 %N 1 %R doi: 10.17098/amj.542438 %U 10.17098/amj.542438
ISNAD Dağcıoğlu, Basri Furkan , Üstü, Yusuf . "Sağlık Taramalarında Danışmanlık Nasıl Yapılmalıdır?". Ankara Medical Journal 19 / 1 (March 2019): 199-204. https://doi.org/10.17098/amj.542438